Foros de Conocimiento
medtronic PRODUCTOS
boston_scientific PRODUCTOS
TERUMO PRODUCTOS
Biotronik PRODUCTOS
Sirtex PRODUCTOS
Striker Neurovascular PRODUCTOS
BIOSENSORS PRODUCTOS

ESTUDIOS


10 febrero 2014

CIRCULATION. Coronary Heart Disease. Trends in Cause of Death After Percutaneous Coronary Intervention

Daniel B. Spoon, MD; Peter J. Psaltis, MBBS, PhD; Mandeep Singh, MD, MPH; David R. Holmes Jr, MD; Bernard J. Gersh, MBChB, DPhil; Charanjit S. Rihal, MD, MBA; Ryan J. Lennon, MS; Issam D. Moussa, MD; Robert D. Simari, MD; Rajiv Gulati, MD, PhD

Background: The impact of changing demographics on causes of long-term death after percutaneous coronary intervention (PCI) remains incompletely defined.

01 enero 2015

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. Angiographic characteristics of definite stent thrombosis: Role of thrombus grade, collaterals, epicardial coronary flow, and myocardial perfusion

Ryan R. Reeves MD1, Mitul Patel MD1, Ehrin J. Armstrong MD MSc2, Shiv Sab MD2, Stephen W. Waldo MD3, Khung-Keong Yeo MBBS2, Kendrick A. Shunk MD, PhD, FACC3,4, Reginald I. Low MD, FACC2, Jason H. Rogers MD, FACC2 andEhtisham Mahmud MD, FACC, FSCAI1,*

Objectives: To characterize the prevalence of thrombus burden, collateral vessels to the infarct-related artery, epicardial coronary artery flow, and myocardial perfusion in patients with angiographically confirmed definite stent thrombosis (ST), and to define their relationship with associated treatments and outcomes.

01 enero 2015

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. Outcomes of preoperative bridging therapy for patients undergoing surgery after coronary stent implantation: A weighted meta-analysis of 280 patients from eight studies

Jeremy Warshauer MD, Vishal G Patel MD, Georgios Christopoulos MD, Anna P. Kotsia MD, Subhash Banerjee MD andEmmanouil S. Brilakis MD, PhD*

Background: Preoperative bridging with a glycoprotein IIb/IIIa inhibitor is often performed in patients with prior coronary stents undergoing surgery who require antiplatelet therapy discontinuation, but its safety and efficacy have received limited study. We performed a weighted meta-analysis of the outcomes in patients with coronary stents undergoing bridging with glycoprotein IIb/IIIa inhibitors prior to surgery.

01 enero 2015

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. Shorter (≤6 months) versus longer (≥12 months) duration dual antiplatelet therapy after drug eluting stents: A meta-analysis of randomized clinical trials

Anil Pandit MD1,*, Smith Giri MD2, Fayaz Ahmad Hakim MD1 andF. David Fortuin MD1

Objective: Optimal duration of dual antiplatelet therapy (DAPT), defined as use of both aspirin and a P2Y12 receptor inhibitor, after implantation of drug eluting stents (DES) is still subject of ongoing debate. We systematically review efficacy and safety of ≤6 months versus ≥12 months DAPT after implantation of DES.

01 enero 2015

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. A combination of plaque components analyzed by integrated backscatter intravascular ultrasound and serum pregnancy-associated plasma protein a levels predict the no-reflow phenomenon during percutaneous coronary intervention

Hyuma Daidoji MD, Hiroki Takahashi MD*, Yoichiro Otaki MD, Harutoshi Tamura MD, Takanori Arimoto MD, Tetsuro Shishido MD, Takehiko Miyashita MD, Takuya Miyamoto MD, Tetsu Watanabe MD andIsao Kubota MD

Aims: Previous studies reported that integrated backscatter intravascular ultrasound (IB-IVUS) provides high diagnostic accuracy for tissue characterization of coronary plaques and that pregnancy-associated plasma protein A (PAPP-A) could be a marker of adverse cardiac outcome in patients with cardiovascular disease. We examined whether IB-IVUS and PAPP-A levels could predict the incidence of no-reflow during percutaneous coronary intervention (PCI)

01 enero 2015

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. Impact of in-hospital bleeding according to the bleeding academic research consortium classification on the long-term adverse outcomes in patients undergoing percutaneous coronary intervention

Yong-Hoon Yoon MD1, Young-Hak Kim MD, PhD1, Seon-Ok Kim MS2, Jong-Young Lee MD1, Duk-Woo Park MD, PhD1, Soo-Jin Kang MD, PhD1, Seung-Whan Lee MD, PhD1, Cheol Whan Lee MD, PhD1, Seong-Wook Park MD, PhD1 andSeung-Jung Park MD, PhD1,*

Objectives: The aim of this study was to assess the impact of bleeding after percutaneous coronary intervention (PCI) with drug-eluting stents on long-term clinical events according to the newly proposed Bleeding Academic Research Consortium (BARC) classification.

01 enero 2015

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. Complex patients treated with zotarolimus-eluting resolute and everolimus-eluting xience V stents in the randomized TWENTE trial: Comparison of 2-year clinical outcome

Hanim Sen MD1, Ming Kai Lam MD1, Kenneth Tandjung MD1, Marije M. Löwik PhD1, Martin G. Stoel MD, PhD1, Frits H.A.F. de Man MD, PhD1, J. (Hans) W. Louwerenburg MD1, Gert K. van Houwelingen MD1, Gerard C.M. Linssen MD, PhD2, Carine J.M. Doggen PhD3, Mounir W.Z. Basalus MD, PhD1 andClemens von Birgelen MD, PhD, FSCAI1,4,*

Objective: To assess the differences in clinical outcome between complex patients treated with Resolute zotarolimus-eluting stents (ZES) versus Xience V everolimus-eluting stents (EES).

01 enero 2015

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. Severe catheter kinking and entrapment during transradial coronary angiography: Percutaneous retrieval using a sheathless guide catheter

Adel Aminian MD1, Douglas G. Fraser MD2 andDariouch Dolatabadi MD1,*

Abstract: The transradial (TR) approach for coronary angiography and intervention is increasingly used worldwide because of several advantages such as reduced bleeding and vascular complications. During TR procedures, aggressive catheter manipulation in the setting of complex and tortuous arterial anatomy can lead to catheter kinking and entrapment. Several percutaneous retrieval techniques using either homolateral radial access or femoral access have been described previously. We demonstrate, for the first time, the use of a sheathless guide catheter as a rescue technique to successfully retrieve a severely kinked and entrapped diagnostic catheter during TR access. © 2014 Wiley Periodicals, Inc.

01 enero 2015

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. Predictors and clinical impact of pre-existing and acquired thrombocytopenia following transcatheter aortic valve replacement

Michael P. Flaherty MD, PhD1,†,*, Amr Mohsen MD1,†, Joseph B. Moore IV, PhD1, Carlo R. Bartoli MD, PhD2, Erik Schneibel MD1, Wasiq Rawasia MD1, Matthew L. Williams MD3, Kendra J. Grubb MD3 andGlenn A. Hirsch MD, MHS1

Background: Data are limited regarding transcatheter aortic valve replacement (TAVR)-related thrombocytopenia (TP). We sought to thoroughly characterize the presence, clinical impact, and severity of TP associated with TAVR.

01 enero 2015

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. Major thrombocytopenia after balloon-expandable transcatheter aortic valve replacement: Prognostic implications and comparison to surgical aortic valve replacement

Hasan Jilaihawi MD, Niraj Doctor MD, Tarun Chakravarty MD, Mohammad Kashif MD, James Mirocha MD, Wen Cheng MD, Michael Lill MD, Mamoo Nakamura MD, Mitch Gheorghiu MD andRaj R. Makkar MD

Objectives: We sought to investigate the magnitude and clinical importance of thrombocytopenia post transcatheter aortic valve replacement (TAVR).

01 enero 2015

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. Novel transcatheter closure of an iatrogenic perimembranous ventricular septal defect

Elizabeth M. Retzer MD1,*, Karin E. Dill MD2 andAtman P. Shah MD1

Abstract: Iatrogenic membranous ventricular septal defects (VSD) are rare complications of cardiothoracic surgery, most commonly seen as a complication of aortic valve replacements. An iatrogenic VSD can lead to right sided heart failure, systemic hypoxia, and arrhythmias, and closure is often necessary. Given the increased mortality associated with repeat surgical procedures, percutaneous transcatheter closure of these iatrogenic VSDs has increasingly become the preferred choice of therapy. We describe the first case of iatrogenic membranous VSD in the setting of mitral valve replacement and tricuspid valve repair, using the newly approved Amplatzer Duct Occluder II Device from an entirely retrograde approach. © 2014 Wiley Periodicals, Inc.

01 enero 2015

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. Severe mitral regurgitation requiring ECMO therapy treated by interventional valve reconstruction using the MitraClip

Dawid L. Staudacher MD*, Christoph Bode MD andTobias Wengenmayer MD

Abstract: Surgical repair is considered the gold standard in severe mitral valve regurgitation. Multi-organ failure because of acute mitral insufficiency, however, can be challenging to manage as it aggravates to an inoperable state. We report the case of a 59 year old woman who presented with pulmonary oedema because of high grade mitral regurgitation. A recompensation prior to surgery using medical therapy failed and the patient developed a progressive multi-organ failure including pulmonary, circulatory, and renal failure within days. Symptomatically, our patient could be stabilized employing an extracorporeal membrane oxygenation and an intra-aortic balloon pump. A surgical mitral valve repair was ruled out because of the multi-organ failure. We performed an interventional valve reconstruction using the MitraClip™ device continuing the extracorporeal membrane oxygenation and the intra-aortic balloon counterpulsation therapy during the procedure. After clipping, multi-organ failure regressed and the extracorporeal membrane oxygenation could be explanted at day two after intervention. © 2013 Wiley Periodicals, Inc.

01 enero 2015

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. SYNTAX score and the risk of stent thrombosis after percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndromes: An ACUITY trial substudy

Mayank Yadav MD1,2,†, Philippe Généreux MD1,2,3,†,*, Tullio Palmerini MD4, Adriano Caixeta MD, PhD5, Mahesh V. Madhavan BA2, Ke Xu PhD1, Sorin J. Brener MD6, Roxana Mehran MD7 andGregg W. Stone MD1,2

Objective: We sought to investigate the relationship between the SYNTAX score (SS) and stent thrombosis (ST) in patients with non-ST-segment elevation acute coronary syndromes (NSTE-ACS) undergoing percutaneous coronary intervention (PCI).

Utilizamos cookies propias para el correcto funcionamiento del sitio web y mejorar nuestros servicios. Pulse el botón Aceptar todas para aceptar su uso. Puede cambiar la configuración u obtener más información en nuestra Política de cookies o pulsando Modificar configuración.